$9.40
00.00%
Last update: 4:00 PM
15 minutes delayed
Centessa Pharmaceuticals: Insider buying and selling updated today.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Mar 26, 2024 | Karen Anderson | CHIEF PEOPLE OFFICER | -6.16K | $7.91 | -$430.71K | SELL | -7.93% | 71.53K | Mar 25 | View |
Feb 02, 2024 | Harris Rotman | SVP REGULATORY AFFAIRS | 29.13K | $8.15 | -$68.22K | GRANT | 86.94% | 62.63K | Feb 01 | View |
Sep 22, 2023 | Harris Rotman | SVP REGULATORY AFFAIRS | 0.00 | $5.33 | -$72.00K | SELL-OPTIONS | 0.00% | 33.50K | Sep 20 | View |
Jun 02, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -6.50K | $4.45 | -$28.95K | SELL | -0.82% | 783.07K | Jun 01 | View |
May 26, 2023 | Tia Bush | CHIEF QUALITY OFFICER | -8.00K | $4.48 | -$35.87K | SELL | -4.85% | 157.10K | May 24 | View |
May 02, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -6.80K | $4.42 | -$30.08K | SELL | -0.85% | 789.57K | May 01 | View |
Apr 04, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.31K | $3.76 | -$38.83K | SELL | -1.28% | 796.37K | Mar 31 - Apr 03 | View |
Mar 03, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -7.00K | $3.42 | -$23.97K | SELL | -0.86% | 806.68K | Mar 01 | View |
Feb 03, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | 69.50K | $3.79 | -$29.20K | GRANT | 9.34% | 813.68K | Feb 01 | View |
Jan 04, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.24K | $3.16 | -$29.17K | SELL | -1.21% | 751.91K | Dec 31 - Jan 04 | View |
Dec 05, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.40K | $3.91 | -$36.74K | SELL | -1.22% | 761.15K | Dec 01 | View |
Nov 03, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.70K | $4.03 | -$39.06K | SELL | -1.25% | 765.06K | Nov 01 | View |
Oct 04, 2022 | DAVID CHAO | CHIEF ADMINISTRATIVE OFFICER | -7.57K | $4.00 | -$30.29K | SELL | -3.28% | 222.93K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | Thomas Templeman | CHIEF TECHNOLOGY OFFICER | -4.46K | $4.00 | -$17.84K | SELL | -3.18% | 135.79K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | DAVID GRAINGER | CHIEF INNOVATION OFFICER | -5.18K | $4.00 | -$20.74K | SELL | -0.55% | 936.08K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | Gregory M Weinhoff | CHIEF FINANCIAL OFFICER | -8.90K | $4.00 | -$35.63K | SELL | -3.71% | 231.10K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -14.99K | $3.94 | -$59.09K | SELL | -1.90% | 774.76K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | IQBAL HUSSAIN | GENERAL COUNSEL | -8.29K | $4.00 | -$33.18K | SELL | -4.92% | 160.21K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | Javad Shahidi | CHIEF MEDICAL OFFICER | -6.07K | $4.00 | -$24.29K | SELL | -3.68% | 158.93K | Sep 30 - Oct 03 | View |
Oct 04, 2022 | Tia Bush | CHIEF QUALITY OFFICER | -4.71K | $4.00 | -$18.87K | SELL | -3.18% | 143.29K | Sep 30 - Oct 03 | View |
Sep 02, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.42K | $4.41 | -$45.99K | SELL | -1.30% | 789.75K | Sep 01 | View |
Aug 03, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.42K | $4.45 | -$46.41K | SELL | -1.29% | 800.17K | Aug 01 | View |
Jul 20, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -20.00K | $4.87 | -$97.31K | SELL | -2.41% | 810.60K | Jul 18 | View |
Jul 06, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | 90.90K | $5.03 | -$45.80K | GRANT | 12.29% | 830.60K | Jul 01 | View |
Jun 27, 2022 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 10.00K | $4.63 | $46.28K | BUY | 35.71% | 38.00K | Jun 24 | View |
Jun 21, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.20K | $4.68 | -$43.04K | SELL | -1.23% | 739.70K | Jun 17 | View |
May 19, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -85.00K | $5.17 | -$439.73K | SELL | -10.19% | 748.90K | May 17 - May 18 | View |
Feb 04, 2022 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 5.00K | $9.74 | $48.70K | BUY | 21.74% | 28.00K | Feb 02 | View |
Feb 01, 2022 | DAVID GRAINGER | CHIEF INNOVATION OFFICER | 27.50K | $9.05 | $248.75K | BUY | 3.38% | 841.26K | Jan 28 | View |
Dec 06, 2021 | Francesco Rubertis De | DIRECTOR | 34.33K | $12.82 | $440.06K | BUY | 11.62% | 329.63K | Dec 02 | View |
Dec 06, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 34.33K | $12.82 | $440.06K | BUY | 11.62% | 329.63K | Dec 02 | View |
Dec 02, 2021 | Francesco Rubertis De | DIRECTOR | 97.15K | $12.24 | $1.19M | BUY | 41.93% | 328.84K | Nov 30 - Dec 01 | View |
Dec 02, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 97.15K | $12.24 | $1.19M | BUY | 41.93% | 328.84K | Nov 30 - Dec 01 | View |
Nov 30, 2021 | Francesco Rubertis De | DIRECTOR | 68.52K | $11.64 | $797.43K | BUY | 26.55% | 326.58K | Nov 26 - Nov 29 | View |
Nov 30, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 68.52K | $11.64 | $797.43K | BUY | 26.55% | 326.58K | Nov 26 - Nov 29 | View |
Nov 18, 2021 | AARON KANTOFF | DIRECTOR | 10.00K | $11.98 | $119.85K | BUY | 20.00% | 60.00K | Nov 18 | View |
Nov 18, 2021 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 23.00K | $12.28 | $282.47K | BUY | ∞ | 23.00K | Nov 16 | View |
Nov 18, 2021 | Tia Bush | CHIEF QUALITY OFFICER | 5.00K | $12.46 | $62.30K | BUY | 166.67% | 8.00K | Nov 16 | View |
Jun 04, 2021 | Francesco Rubertis De | DIRECTOR | 2.53M | $20.00 | $12.00M | BUY | ∞ | 325.00K | Jun 02 | View |
Jun 04, 2021 | DAVID CHAO | CHIEF ADMINISTRATIVE OFFICER | 500.00 | $20.00 | $10.00K | BUY | ∞ | 500.00 | Jun 02 | View |
Jun 04, 2021 | Tia Bush | CHIEF QUALITY OFFICER | 3.00K | $20.00 | $60.00K | BUY | ∞ | 3.00K | Jun 02 | View |
Jun 04, 2021 | Thomas Templeman | CHIEF TECHNOLOGY OFFICER | 250.00 | $20.00 | $5.00K | BUY | ∞ | 250.00 | Jun 02 | View |
Jun 04, 2021 | IQBAL HUSSAIN | GENERAL COUNSEL | 8.50K | $20.00 | $170.00K | BUY | ∞ | 5.50K | Jun 02 | View |
Jun 04, 2021 | ARJUN GOYAL | DIRECTOR | 3.93M | $20.00 | $15.00M | BUY | ∞ | 106.16K | Jun 02 | View |
Jun 04, 2021 | Marella Thorell | CHIEF ACCOUNTING OFFICER | 1.00K | $20.00 | $20.00K | BUY | ∞ | 1.00K | Jun 02 | View |
Jun 04, 2021 | Gregory Weinhoff | CHIEF FINANCIAL OFFICER | 10.00K | $20.00 | $200.00K | BUY | ∞ | 10.00K | Jun 02 | View |
Jun 04, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 2.53M | $20.00 | $12.00M | BUY | ∞ | 325.00K | Jun 02 | View |
Jun 03, 2021 | GAP Bermuda LTDGENERAL ATLANTIC GENPAR BERMUDA LPrl Sa Lux Atlantic GeneralSCSp Lux GenPar Atlantic GeneralGeneral Atlantic Cooperatief LPSCSp Lux Partners Atlantic GeneralGeneral Atlantic Partners Bermuda EU LPGeneral Atlantic Partners Bermuda IV LPUA Cooperatief Atlantic GeneralBV UM Atlantic General | DIRECTOR | 1.50M | $20.00 | $30.00M | BUY | 18.33% | 9.68M | Jun 02 | View |
Browse insider trades on all stocks.